![Christoph Bausch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christoph Bausch
Chief Operating Officer at
SAB BIOTHERAPEUTICS, INC.
Net worth: - $ as of 31/07/2026
Profile
Christoph Bausch is the founder of Nanopore Diagnostics LLC.
Dr. Bausch is the Chief Operating Officer at SAB Biotherapeutics, Inc. since 2022.
Dr. Bausch attended the University of Nebraska for undergraduate studies, St. Louis University for an MBA, and The Ohio State University for a doctorate.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 02/03/2026 | 0 ( -.--% ) | - $ | 31/07/2026 |
Christoph Bausch active positions
| Companies | Position | Start |
|---|---|---|
| SAB BIOTHERAPEUTICS, INC. | Chief Operating Officer | 01/05/2022 |
Former positions of Christoph Bausch
| Companies | Position | End |
|---|---|---|
Nanopore Diagnostics LLC
 Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Founder | - |
Training of Christoph Bausch
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
33
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Nebraska
 University of Nebraska Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Ohio State University
 The Ohio State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nanopore Diagnostics LLC
Nanopore Diagnostics LLC Medical SpecialtiesHealth Technology Develops portable platform for counting microbes | Health Technology |
SAB Biotherapeutics, Inc.
 SAB Biotherapeutics, Inc. BiotechnologyHealth Technology Engages in advancing a new class of immunotherapies | Health Technology |
- Stock Market
- Insiders
- Christoph Bausch
